{"id":636350,"date":"2026-08-14T06:49:28","date_gmt":"2026-08-14T06:49:28","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/636350\/"},"modified":"2026-08-14T06:49:28","modified_gmt":"2026-08-14T06:49:28","slug":"the-fda-issued-a-recall-on-bladder-medication-nationwide","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/636350\/","title":{"rendered":"The FDA Issued a Recall on Bladder Medication Nationwide"},"content":{"rendered":"<p>Key Points<\/p>\n<ul class=\"mb-4\">\n<li class=\"ml-4 safari:ml-6 list-disc\">\n<p class=\"mb-4 text-lg md:leading-8 break-words\">A nationwide recall was issued for mirabegron tablets due to an impurity in the active ingredient.<\/p>\n<\/li>\n<li class=\"ml-4 safari:ml-6 list-disc\">\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The recall is classified as Class II, meaning it may cause temporary or reversible health effects.<\/p>\n<\/li>\n<li class=\"ml-4 safari:ml-6 list-disc\">\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Check your medication and contact your pharmacy for a refund or replacement if you have the recalled product.<\/p>\n<\/li>\n<\/ul>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">There&#8217;s an ongoing recall on a specific type of bladder medication distributed and prescribed nationwide, according to the U.S. Food and Drug Administration (FDA).\u00a0This is due to an impurity issue.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The medication being recalled is 25-milligram, 30-count bottles of mirabegron extended-release tablets manufactured by Zydus Lifesciences. The recalled bottles contain a lot code of &#8220;E408618,&#8221; an NDC of &#8220;70710-1159-3&#8221; and the expiration date &#8220;11\/30\/2026.&#8221;<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">The bladder medication, prescribed to treat <a data-ylk=\"slk:overactive bladder;elm:context_link;itc:0;sec:content-canvas;\" data-yga=\"{&quot;yLinkElement&quot;:&quot;link&quot;,&quot;yLinkElementType&quot;:&quot;article_link&quot;}\" href=\"https:\/\/www.eatingwell.com\/foods-to-eat-for-overactive-bladder-11755405\" rel=\"noopener noreferrer nofollow\" target=\"_blank\">overactive bladder<\/a>\u00a0symptoms, is being recalled due to an out-of-specification test result that confirmed an impurity for the active ingredient mirabegron. Therefore, this recall has been classified as Class II, meaning that taking these pills may cause &#8220;temporary or medically reversible adverse health consequences.&#8221;<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Check your medication, and if you have the recalled product on hand, contact your pharmacy for a refund or replacement. Seek medical attention if you are experiencing any health concerns after consuming the affected pills.<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">For questions about this recall, contact the FDA by calling 1-888-INFO-FDA (1-888-463-6332).<\/p>\n<p class=\"mb-4 text-lg md:leading-8 break-words\">Read the original article on <a data-ylk=\"slk:EatingWell;elm:context_link;itc:0;sec:content-canvas;\" data-yga=\"{&quot;yLinkElement&quot;:&quot;link&quot;,&quot;yLinkElementType&quot;:&quot;article_link&quot;}\" href=\"https:\/\/www.eatingwell.com\/mirabegron-bladder-medication-recall-12058210\" rel=\"noopener noreferrer nofollow\" target=\"_blank\">EatingWell<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Key Points A nationwide recall was issued for mirabegron tablets due to an impurity in the active ingredient.&hellip;\n","protected":false},"author":2,"featured_media":636351,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[274],"tags":[268912,18,6915,135,19,17,462,130187],"class_list":["post-636350","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-active-ingredient","tag-eire","tag-food-and-drug-administration","tag-health","tag-ie","tag-ireland","tag-medication","tag-recalled-product"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/117092533302163625","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/636350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=636350"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/636350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/636351"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=636350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=636350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=636350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}